Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies-Reference-Cited by-同舟云学术

Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies

Published:2021-04 Issue:4 Volume:35 Page:345-384
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Gatti Milo^ORCID,De Ponti Fabrizio^ORCID,Pea Federico^ORCID

Funder

Alma Mater Studiorum - Università di Bologna

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40263-021-00811-2.pdf

Reference104 articles.

1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3.

2. WHO. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Accessed 22 Dec 2020.

3. WHO. Virtual press conference on COVID-19, 11 March 2020. Available from: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic. Accessed 22 Dec 2020.

4. European Centre for Disease Prevention and Control. COVID-19 situation update worldwide. Available from: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases. Accessed 22 Dec 2020.

5. Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal. J Heart Lung Transplant. 2020;39(5):405–7.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanomaterials as a Versatile Tool for COVID-19 Treatment;BioNanoScience;2024-08-07

2. Drug-Drug Interactions Between COVID-19 Treatments and Psychotropic Medications: An Updated Study;Cureus;2023-12-13

3. Drug-drug interactions between COVID-19 drug therapies and antidepressants;Expert Opinion on Drug Metabolism & Toxicology;2023-11-30

4. Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis;Antibiotics;2023-04-16

5. The Cytokine Release Syndrome and/or the Proinflammatory Cytokines as Underlying Mechanisms of Downregulation of Drug Metabolism and Drug Transport: A Systematic Review of the Clinical Pharmacokinetics of Victim Drugs of this Drug–Disease Interaction Under Different Clinical Conditions;Clinical Pharmacokinetics;2022-09-05